PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-240.92%
Both yoy net incomes decline, with CSIQ at -64.54%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
16.39%
Less D&A growth vs. CSIQ's 100.00%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-240.35%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-11.41%
Both cut yoy SBC, with CSIQ at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-417.35%
Negative yoy working capital usage while CSIQ is 100.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-125.90%
Both yoy AR lines negative, with CSIQ at -100.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-300.90%
Negative yoy inventory while CSIQ is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
354.74%
A yoy AP increase while CSIQ is negative at -100.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-187.38%
Negative yoy usage while CSIQ is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.38%
Well above CSIQ's 73.52%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-4410.58%
Negative yoy CFO while CSIQ is 100.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-66.78%
Both yoy lines negative, with CSIQ at -100.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Some acquisitions while CSIQ is negative at -100.00%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
12994.15%
Liquidation growth of 12994.15% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-6545.05%
We reduce yoy other investing while CSIQ is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
200.90%
We have mild expansions while CSIQ is negative at -100.00%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-161.73%
We cut debt repayment yoy while CSIQ is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-193.28%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.